ACTU vs PLD · $49.0M cap vs P/E 27, rev $8.79B
Actuate Therapeutics, Inc. Common stock (ACTU) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Actuate Therapeutics, Inc. Common stock (ACTU) is a biotechnology company listed on NASDAQ.
Prologis Inc (PLD) is a reit - industrial company listed on US.
ACTU does not have a complete income-statement cache yet.
Latest reported PLD revenue for 2025-12-31 was $8.79B. Net income was $3.33B. Revenue was up 7.2% from 2024-12-31 to 2025-12-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
ACTU currently screens at market cap $49.0M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the ACTU and PLD stock pages for the full models.
Not investment advice.